These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25026900)

  • 21. Decreased Mitochondrial Function Among Healthy Infants Exposed to Antiretrovirals During Gestation, Delivery and the Neonatal Period.
    Noguera-Julian A; Morén C; Rovira N; Garrabou G; Catalán M; Sánchez E; Cardellach F; Miró Ó; Fortuny C
    Pediatr Infect Dis J; 2015 Dec; 34(12):1349-54. PubMed ID: 26372453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
    J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
    N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of mother-to-child transmission of HIV in pregnancy and among HIV-exposed infants accessing care at a PMTCT clinic in southwest Nigeria.
    Afolabi AY; Bakarey AS; Kolawole OE; Kola OJ
    J Immunoassay Immunochem; 2018; 39(4):403-415. PubMed ID: 30001188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
    Briand N; Warszawski J; Mandelbrot L; Dollfus C; Pannier E; Cravello L; Nguyen R; Matheron I; Winer N; Tubiana R; Rouzioux C; Faye A; Blanche S;
    Clin Infect Dis; 2013 Sep; 57(6):903-14. PubMed ID: 23728147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
    JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of highly active anti-retroviral therapy on prevention of mother to child transmission of HIV and on infant growth and development].
    He Y; Luo Y; Ding YL; Zheng YH; Li J; Huang J; Li JM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Oct; 45(10):912-5. PubMed ID: 22321592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Why are HIV-infected infants still being born in Spain?].
    Fernández-Ibieta M; Ramos Amador JT; Guillén Martín S; González-Tomé MI; Navarro Gómez M; Iglesias González-Nicolás E; Rubio Gribble B; de José Gómez MI; Beceiro Mosquera J; Regidor J; De Santos Butragueño MJ; Martínez Guardia N; Roa Francia MA
    An Pediatr (Barc); 2007 Aug; 67(2):109-15. PubMed ID: 17692255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
    Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
    JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine.
    Baroncelli S; Pinnetti C; Genovese O; Tamburrini E; Floridia M
    J Med Virol; 2011 Mar; 83(3):551-6. PubMed ID: 21264878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.
    American Academy of Pediatrics Committee on Pediatric AIDS
    Pediatrics; 2008 Nov; 122(5):1127-34. PubMed ID: 18977995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early Initiation of ARV During Pregnancy to Move towards Virtual Elimination of Mother-to-Child-Transmission of HIV-1 in Yunnan, China.
    Meyers K; Qian H; Wu Y; Lao Y; Chen Q; Dong X; Li H; Yang Y; Jiang C; Zhou Z
    PLoS One; 2015; 10(9):e0138104. PubMed ID: 26407096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of vertical HIV-1 transmission in a tertiary care public hospital in Buenos Aires, Argentina].
    Cecchini D; Martinez M; Astarita V; Nieto C; Giesolauro R; Rodriguez C
    Rev Panam Salud Publica; 2011 Sep; 30(3):189-95. PubMed ID: 22069064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower Preprandial Insulin and Altered Fuel Use in HIV/Antiretroviral-Exposed Infants in Cameroon.
    Jao J; Kirmse B; Yu C; Qiu Y; Powis K; Nshom E; Epie F; Tih PM; Sperling RS; Abrams EJ; Geffner ME; LeRoith D; Kurland IJ
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3260-9. PubMed ID: 26133363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of concurrent exposure to antiretrovirals and cotrimoxazole prophylaxis among HIV-exposed, uninfected infants.
    Ewing AC; King CC; Wiener JB; Chasela CS; Hudgens MG; Kamwendo D; Tegha G; Hosseinipour MC; Jamieson DJ; Van der Horst C; Kourtis AP
    AIDS; 2017 Nov; 31(18):2455-2463. PubMed ID: 28926409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of HIV-1 drug-resistant variants in women following antiretroviral prophylaxis for the prevention of mother to child transmission.
    Mani M; Ramalingam VV; Lionel J; Christina SA; Sachithanandham J; Peedicayil A; Kannangai R
    Indian J Med Microbiol; 2015; 33(2):225-30. PubMed ID: 25865972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
    Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
    Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence of antiretroviral prophylaxis on growth of HIV-exposed uninfected infants].
    Hu F; Lu JJ; Liang JJ; Zhu S; Yu J; Zou XW; Hu Y; Lin SF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jul; 40(7):770-774. PubMed ID: 31357796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.